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RESUMO 
 
 As doenças não transmissíveis são por definição não infeciosas e não 
transmissíveis de pessoa para pessoa. Este grupo de doenças, em particular as doenças 
cardiovasculares, o cancro, a diabetes e as doenças respiratórias, lideram mundialmente 
o número de mortes. A mortalidade precoce é uma das consequências destas doenças 
que gera maior preocupação, assim como, a perda de qualidade de vida levando os 
indivíduos a viver um considerável número de anos com incapacidade para trabalhar 
segregando as famílias para situações de pobreza. 
 As doenças cardiovasculares representam a maior causa de morte, com 15.6 
milhões de mortes em 2010, de entre as quais se destacam o enfarte agudo do miocárdio 
e os acidentes vasculares cerebrais. O cancro representa a segunda maior causa de 
mortalidade, responsável por 8 milhões de mortes em 2010, sendo expectável que venha 
a aumentar a sua incidência em todo o mundo, em particular nos países com menor 
nível de desenvolvimento. O cancro da traqueia, brônquios e pulmão são os mais 
frequentes, quase do dobro do cancro do estômago e fígado conjuntamente. Como 
terceira causa de morte surge a doença pulmonar obstrutiva crónica, a mais 
representativa do grupo das doenças crónicas respiratórias que são responsáveis por 3.8 
milhões de mortes. Por último, a diabetes é responsável por 12.8 milhões de mortes, 
tendo também a particularidade de ser percursora de outras doenças, como por exemplo, 
os acidentes cerebrais vasculares ou a insuficiência renal.  
 Este grupo de doenças partilha um conjunto de fatores de risco bem identificados 
e que são similares em todos os países. Os quatro fatores de risco comportamentais que 
estão fortemente relacionados com as doenças não transmissíveis, anteriormente 
identificadas, são: tabagismo, dietas alimentares desadequadas, sedentarismo e consumo 
abusivo de álcool. Estes conduzem a quatro importantes alterações metabólicas: 
hipertensão arterial, obesidade, hiperglicemia e hiperlipidemia. No entanto, inerente ao 
desenvolvimento do país ou ao grupo socioeconómico a que o indivíduo pertence existe 
um conjunto de fatores mais amplos e menos passíveis de mudança a curto e médio 
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prazo que também condicionam o aparecimento das doenças não transmissíveis, tais 
como o rendimento, o acesso à educação ou a poluição atmosférica. 
 Por forma a prevenir ou controlar as doenças não transmissíveis, em particular 
estas doenças crónicas, a Organização Mundial de Saúde (OMS) propõe que sejam 
implementadas um conjunto de medidas específicas dirigidas aos fatores de risco 
comportamentais. A OMS identificou um grupo de medidas custo-efetivas para estes 
dois grupos de fatores de risco, como por exemplo, proibir fumar em locais públicos, 
adverter a população para o impacto negativo do tabagismo na saúde, aumentar os 
impostos sobre o tabaco, reduzir a quantidade de sal na comida, assim como, 
proporcionar à população rastreios do cancro do colo do útero e da mama para deteção e 
tratamento precoces do cancro.  
 Neste sentido, os decisores políticos dos diferentes países assumem um papel 
especialmente importante na gestão dos sistemas de saúde. A promoção de hábitos de 
vida saudáveis e as intervenções de rastreio pressupõem um melhor acesso aos serviços 
de saúde, em particular aos cuidados de saúde primários. A avaliação de desempenho 
dos sistemas de saúde tem sido um tema frequente entre os decisores políticos 
principalmente desde 2000, ano em que a OMS dedicou um relatório a este tema. A 
comparação do desempenho dos sistemas de saúde entre países tem sido levada a cado 
por diversos investigadores e reconhecida como importante por alguns autores. Os 
sistemas de saúde são extremamente complexos e a sua avaliação de desempenho tem 
um papel importante ao proporcionar informação relevante aos diferentes agentes que 
neles participam por forma a tomarem decisões informadas no sentido de atingirem os 
objetivos propostos. 
 Diversos estudos utilizando o Data Envelopment Analysis (DEA) para comparar 
a eficiência dos sistemas de saúde de diversos países foram desenvolvidos ao longo das 
últimas décadas, no entanto, menos estudos foram efetuados para avaliar a efetividade 
dos sistemas de saúde. Seja sobre eficiência ou efetividade grande parte dos estudos 
desenvolvidos avalia os sistemas de saúde como um todo. Neste sentido, esta 
dissertação introduz um contributo ao ter como principal objetivo explorar o potencial 
do DEA para avaliar a efetividade dos sistemas de saúde na prevenção e controlo das 
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doenças não transmissíveis. Para este efeito, foram recolhidos dados de 27 países da 
OCDE para o ano de 2009. 
 Os resultados obtidos apontam 11 países como efetivos na prevenção e controlo 
das doenças não comunicáveis. Os países considerados efetivos são: Finlândia, Grécia, 
Islândia, Israel, República da Coreia, Luxemburgo, México, Polónia, Eslovénia, 
Espanha e Suíça. De entre os quais, Israel e a Finlândia são os que mais vezes servem 
de referência para aprendizagem para os países não efetivos na prevenção e controlo das 
doenças não comunicáveis.  
 Os resultados do nosso estudo sugerem ainda que Israel e a Finlândia destacam-
se particularmente na prevenção e controlo das doenças cardiovasculares e neoplasias, 
respetivamente. De facto, a OMS reconhece Israel como detentor de uma excelente rede 
de serviços de cuidados primários composta por equipas multidisciplinares próximas da 
comunidade proporcionando um melhor acesso a cuidados de saúde. A proximidade 
destas equipas multidisciplinares oferece, por um lado, maior oportunidade para 
promover hábitos de vida saudáveis junto da população, e por outro, controlar 
sistematicamente as pessoas que já se encontram em situação de doença. A Finlândia 
tem das taxas de incidência de cancro mais baixas da Organização para a Cooperação e 
Desenvolvimento Económico (OCDE), em particular a do cancro do pulmão. Por trás 
destes resultados está um forte investimento em programas de controlo do tabagismo e 
programas de rastreio de cancro (por exemplo, mamografias). Os programas de controlo 
do tabagismo têm sido baseados tanto em fortes campanhas publicitárias como em 
restrições de acesso e consumo legisladas desde meio da década de 90. 
 Os resultados obtidos indicam que há uma variação significativa na efetividade 
da prevenção e controlo das doenças não transmissíveis nos países analisados, 
sugerindo que a identificação das melhores práticas neste contexto poderá resultar na 
implementação de estratégias mais efetivas na prevenção e controlo destas doenças 
junto da população. Estes resultados também demonstram o potencial papel estratégico 
do DEA para um planeamento mais efetivo dos recursos existentes. 
Palavras-chave: doenças não transmissíveis, DEA, sistema de saúde, efetividade. 
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ABSTRACT 
 
 Noncommunicable diseases (NCDs), with special relevance cardiovascular 
diseases, cancer, diabetes and respiratory diseases, are leading causes of death 
worldwide. For policymakers across countries, the prevention and control of these 
diseases is fundamental to ensure an effective management of healthcare systems. The 
main purpose of this dissertation is to explore the potential of using Data Envelopment 
Analysis (DEA) to assess the effectiveness of healthcare systems in preventing and 
controlling NCDs. To this purpose, data from 27 OECD counties has been used. Our 
results point out a remarkable variation in NCDs prevention and control across 
countries, suggesting that the identification of best practices in this context may 
contribute to the development of more effective strategies to prevent and control NCDs 
among the population. These results also demonstrate the potential strategic role of 
DEA for an effective planning of the available resources.  
Keywords: NCDs, DEA, healthcare system, effectiveness. 
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1. INTRODUCTION 
 Noncommunicable diseases (NCDs) are a group of medical conditions or 
diseases that are by definition non-infectious and non-transmissible from person to 
person (Kim and Oh, 2013). Although, NCDs include psychiatric, neurological, 
musculoskeletal, gastrointestinal and kidney diseases, the World Health Organization 
(WHO) (WHO, 2000a; WHO, 2008; WHO, 2011) considers four principal types of 
NCDs: cardiovascular diseases (including stroke and heart disease), diabetes, cancers 
and chronic respiratory diseases (including chronic obstructive pulmonary disease and 
asthma). These NCDs are the leading cause of mortality all over the world, causing 
more deaths than all other causes combined, and are no longer an issue of relevance to 
high income countries only, as recently they have hit with high incidence the low- and 
middle-income countries (WHO, 2011).  
 From a total of 57 millions of deaths all over the world in 2008, 36 million, or 
63%, were due to NCDs (World Health Assembly, 2013). The premature mortality is 
one of the most important implications of NCDs, as the numbers reveal that about a 
quarter of the deaths occur before the age of 60, mainly in low and middle-income 
countries (Chand, 2012). Without preventable measures and actions on the field, 
according to the Global Status Report on NCDs 2010 (WHO, 2011) it is expectable that 
the number of deaths due to NCDs will rise to 52 million by 2030. 
 There are several risk factors identified for increasing the mortality due to NCDs. 
As the Global Status Report on NCDs 2010 refers, “A large percentage of NCDs are 
preventable through the reduction of their main behavioral risk factors: tobacco use, 
physical inactivity, harmful use of alcohol and unhealthy diet.” (WHO, 2011: 1). 
According to the same report, the behavioral risks, previously mentioned, are 
responsible for about 80% of coronary heart disease and cerebrovascular disease. 
 However, the risk factors are wider than those previously described and Chand 
(2012: 2) remembers that “the risk factors for NCDs are social, environmental, 
behavioral and biological”, with the behavioral risk factors influencing the biological 
ones such as blood glucose, lung function or brain chemistry. Also, “social and 
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environmental factors such as urbanization, air pollution or consumption trends may 
influence behavior and biology” Chand (2012: 2). NCDs are caused by multiple risk 
factors, some are individual options and can be modified, others are more embracing 
and must be addressed by policymakers for wider changes.  
 NCDs have a very important impact on the global economy and on each 
country’s economy in particular. Health expenditure is a very important part of the 
public budget and the WHO (2011: 36) refers that “national health-care budgets are 
increasingly allocated to treatment of cardiovascular diseases, cancer, diabetes, and 
chronic respiratory disease”. However, NCDs have other important implications on the 
society1: an unhealthy population leads to a loss of productivity and to high levels of 
absenteeism. According to the World Economic Forum, by 2030 the cumulative loss in 
global economic output due to NCDs will be $47 trillion, representing 5% of the Gross 
Domestic Product (GDP) (Bloom et al., 2011).  
 The World Health Assembly (2013: 10) as a follow-up to the political 
declaration of the high-level meeting of the general assembly on the prevention and 
control of NCDs reinforces that: 
“…for all countries, the cost of inaction far outweighs the cost of 
taking action on noncommunicable disease (…) the total cost of 
implementing a combination of very cost-effective population-wide and 
individual interventions, in terms of current health spending, amounts 
to 4% in the low-income countries, 2% in the lower middle-income 
countries and less than 1% in upper middle- income and high-income 
countries.” 
 Considering that the resources for healthcare systems are limited and the level of 
health expenditure is always a concern for all governments in all countries, having the 
right information to take the best decisions has a precious value to policymakers. 
Therefore, performance assessment in this field plays a crucial role as it helps “hold the 
various agents to account by enabling stakeholders to make informed decisions” (Smith 
                                                           
1
 The World Economic Forum includes mental health disorders as one of the most important NCDs. 
However given their global burden, their cost and the type of interventions needed to prevent and control 
these disorders, they should be analyzed separately. For that reason, in this study, as previously discussed, 
we will only focus on the four main categories of NCDs: cardiovascular diseases, diabetes, cancers and 
chronic respiratory diseases. 
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et al. 2009a:5). By offering timely information about the structure, processes and 
outcomes (Donabedian, 1980), performance assessment can contribute to improve 
health systems. A particularly valuable way to improve these systems consists in 
identifying and sharing the best practices, however, the identification of the best 
practices is complex since there are multiple factors contributing for health outcomes. 
Furthermore, the complexity increases at macro-level benchmarking, due to geographic, 
economical, cultural, social and political issues.  
 Data Envelopment Analysis (DEA) is a non-parametric linear programming 
technique developed by Charnes, Cooper and Rhodes (1978) to measure the relative 
efficiency of homogeneous Decision Making Units (DMUs). In the past two decades, 
the DEA technique has been extensively used in the health care field and different 
levels of DMUs have been considered. According to Ozcan (2008) the application of 
DEA not only allows the identification of top performers but also conduces to 
discovering alternative ways for health care performance improvement. As emphasized 
by Santos, Amado and Santos (2012) one of the interesting features of DEA is that it 
allows each unit to identify a benchmarking group; that is, a group of units that are 
following the same objectives and priorities, but performing better.  
 We can find many studies that have applied DEA at the micro-level (e.g. 
comparing hospitals or clinics in a particular country or region). However, there are 
considerably less studies using DEA at the macro-level (e.g. comparing healthcare 
systems of several countries). Examples of studies at the macro-level are those of: 
Hadad, Hadad and Simon-Tuval (2013); Santos et al. (2012); Afonso and Aubyn 
(2011); Hollingsworth (2008); Retzlaff-Roberts, Chang and Rubin (2004) and Puig-
Junoy (1998). Whilst most of these studies take advantage of the rich database available 
for OECD countries, undertaking comparisons of health systems performance across 
these countries, Santos et al. (2012) compare the efficiency of mother to child HIV 
prevention in low-and middle-income countries. Despite the potential of DEA to 
evaluate the performance of health systems in controlling specific diseases, to the best 
of our knowledge, there is no published study using DEA to undertake an international 
comparison of the performance of countries in controlling and preventing NCDs. 
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 The aim of this research is to contribute to this under-researched area by 
exploring the potential of using the DEA technique to assess the effectiveness of NCDs 
prevention and control in OECD countries. In particular, we aim to: a) identify the most 
effective countries in NCDs prevention and control; b) identify some of the most 
relevant reasons behind the levels of performance achieved by the most effective 
countries; and c) suggest improvement actions.  
 In order to achieve these objectives, the dissertation is organized as follows. 
Section 2 discusses the importance of the NCDs control and prevention, discusses their 
impact on healthcare systems and expenditure, and gives an overview of the DEA 
methodology discussing the extent to which its use has been documented for health 
systems performance assessment. Section 3 presents the DEA model developed to 
accomplish the purpose of this study and then discusses the empirical results obtained. 
Finally, Section 4 concludes the dissertation with some closing remarks and suggestions 
for future research. 
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2. LITERATURE REVIEW 
2.1. The importance of comparing health systems performance in preventing and 
controlling NCDs 
 NCDs have a severe impact on individuals, communities and countries. This 
rapidly changing health and disease profile has serious implications for poverty 
reduction and economic development. The analysis of the Global Burden of Disease 
Study 2010 (Lozano et al., 2012) revealed that NCDs were responsible for almost 35 
million deaths (or 65.5% of all deaths) and chronic NCDs have a special role in it. 
Cardiovascular diseases represent the most important causes of death, in which 
ischemic heart disease is the major cause followed by stroke. Cancer represents the 
second group of NCDs which causes more losses. The third leading cause of all deaths 
is chronic obstructive pulmonary disease (COPD), the most representative from the 
chronic respiratory diseases. Diabetes deaths worldwide almost doubled from 1990 to 
2010, becoming one of the most important causes of death.  
 Premature mortality 2  is a very concerning issue because no one should be 
doomed to die prematurely. Nonetheless, premature mortality is not the only relevant 
issue in NCDs because these diseases also reduce people’s quality of life, leading 
individuals to live a considerable amount of years with incapacity to work and pushing 
families to poverty. According to the Global Burden of Disease Study 2010 the 
distribution of DALYs3 in 2010 reflect a predominance of NCDs globally, with 54% of 
all DALYs due to NCDs (Lozano et al., 2012). In order to give relevant background 
information to support the analysis, in what follows we will review some facts about 
each of the four main groups of NCDs (cardiovascular diseases, diabetes, cancers and 
chronic respiratory diseases).  
                                                           
2 WHO (2011) defines ‘premature death’ as a death of a person with less than 70 years old. 
3 The disability-adjusted life years (DALYs) are the sum of two components: years of life lost due to 
premature mortality (YLLs) and years lived with disability (YLDs).  In other words, it is a measure of 
overall disease burden, expressed as the number of potential productive years lost due to premature ill-
health, disability or early death (Murray et al., 2012). 
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 Cardiovascular diseases keep leading the global causes of death with 15.6 
million or 29.5% of all deaths (Lozano et al., 2012) and this number is expected to 
increase, achieving more than 23.6 million by 2030 (WHO, 2012). Cardiovascular 
diseases accounted for 11.8% of the total DALYs. Policymakers have to invest in the 
prevention and control of these diseases or $47 trillion will be lost in the next 25 years 
(Laslett et al., 2012). 
 Cancer is predicted to be an increasing cause of death (4 million per year) and 
disability in the next few decades. Overall, an estimated 12.7 million new cancer cases 
and 7.6 million cancer deaths occurred in 2008, with 56% of the new cancer cases and 
63% of the cancer deaths occurring in the less developed regions of the world (Ferlay et 
al., 2010). More recent data shows that neoplasms caused in 2010 almost 8 million 
deaths, representing 15.1% of all causes of death and 23% of all NCDs deaths. Trachea, 
bronchus and lung cancer are the most frequent (1.5 million or 19.1% of neoplasm 
deaths) almost doubling the deaths when compared with the next two most common, 
stomach and liver cancer (Lozano et al., 2012). As expected, neoplasms have an 
important accounting on DALYs representing 7.6% of global DALYs (Murray et al., 
2012). 
 High-income countries had more than twice the rate of all cancers combined 
when compared with the lower-income countries. Whilst a considerable increase in 
cancer incidence is expected worldwide in the next two decades, the low- and low-
middle-income countries will have a higher increase (82% and 70%, respectively) when 
compared to the high-income countries (40%) (WHO, 2011). 
 The report “The Global Economic Cost of Cancer”, released at the 2010 World 
Cancer Congress in China, reveals that the total economic impact of premature death 
and disability from cancer worldwide was $895 billion in 2008 (1.5% of world’s GDP), 
in which lung cancer, trachea and bronchus represent the largest drain, nearly $180 
billion on the global economy (John and Ross, 2010). 
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 Chronic respiratory diseases represent, in turn, 3.8 million deaths, wherein 
COPD represents 76.7% of these diseases. Although the number of deaths from COPD 
has decreased from 1990 to 2010 (3.1 million to 2.9 million), it is relevant to emphasize 
that the massive increase in tobacco use since the 1970s might reverse this trend over 
the next decade or so (Lozano et al., 2012). Chronic respiratory diseases are responsible 
for 4.7% of global DALYs, with COPD making up two thirds of the total (Murray et al., 
2012).  
 Lastly, diabetes is a common chronic disease that is rapidly rising in prevalence 
(Guariguata et al., 2013; Caspersen et al., 2012) representing 12.8 million deaths 
(Lozano et al., 2012) and 1.9% of all DALYs in 2010 (Murray et al., 2012). Diabetes is 
an important illness as having diabetes increases the risk of getting other diseases, for 
example, it increases twice the risk of having a stroke and it is responsible for several 
conditions that decrease the quality of life. Some of the diabetes complications are: 
renal failure, lower limb amputation, visual impairment and blindness. Furthermore, 
having diabetes increases the risk of getting tuberculosis (WHO, 2011). All these 
conditions and complications have an impact on global health expenditure. Dealing with 
diabetes represented a health care related expenditure of at least $376 billion in 2010 
and will represent $490 billion in 2030. Globally, 12% of the total health care 
expenditure is expected to have been spent on diabetes in 2010. More than 90% of the 
global expenditure on diabetes is made in the world’s economically richest countries 
and the USA are leading this group (spending more than half of the global expenditure 
on diabetes) (Zhang et al., 2010). 
 Behind these diseases a few main modifiable risk factors are identified and are 
similar in all countries (Ezzati et al., 2002). Four behavioral risk factors are strongly 
associated and causally linked to NCDs: tobacco use, unhealthy diet, physical inactivity 
and harmful consumption of alcohol. These individual behaviors lead to four 
metabolic/physiological changes: raised blood pressure, overweight/obesity, 
hyperglycemia and hyperlipidemia (WHO, 2011). The leading risk factor is raised blood 
pressure (13% of global deaths are attributable to this risk factor), followed by tobacco 
use (9%), raised blood glucose (6%), physical inactivity (6%), and overweight/obesity 
(5%) (WHO, 2009). 
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 Tobacco use comes in both smokeless and smoking forms, however, smoking 
tobacco is the most commonly used form globally (WHO, 2011). Smoking is estimated 
to cause about 71% of all lung cancer deaths, 42% of chronic respiratory diseases and 
about 10% of cardiovascular diseases (Line, Ezzati and Murray, 2007). If prevention 
actions fail, by 2020 tobacco related deaths are expected to increase to 7.5 million, 
accounting for 10% of all deaths (Mathers and Loncar, 2006).  
 Insufficient physical activity is also a behavioral risk factor and is responsible for 
almost 3.2 million deaths, representing 4% of all DALYs (WHO, 2009). People who are 
physically inactive have a 20 to 30% increased risk of all causes of mortality compared 
to those who engage in at least 30 minutes of moderate intensity of physical activity on 
most days of the week (WHO, 2010). Physical activity decreases the risk of several 
cardiovascular diseases, like stroke and ischemic heart disease, but also cancer and 
diabetes. Men tend to be more active than women in all regions, but the high income 
countries lead physical inactivity levels in both sexes, where 41% of men and 48% of 
women are insufficiently physically active (WHO, 2011). 
 A balanced diet is composed by different aspects and therefore there are no 
estimates of unhealthy diet prevalence. However, there are some relevant aspects to take 
into consideration. In particular, the low fruit and vegetable consumption is estimated to 
cause 1.7 million deaths worldwide, representing 1.0% of all DALYs. The WHO 
recommends the intake of 400 grams of fruits and vegetables each day contributing to 
decrease the risk of cardiovascular diseases, diabetes mellitus (Bazzano, 2005) and 
cancer (Riboli and Norat, 2003). The amount of salt consumed is another concern 
because it plays an important role on blood pressure levels. The WHO recommends less 
than 5 grams per person per day, because reducing salt intake would have an important 
impact on decreasing the prevalence of cardiovascular diseases (WHO, 2007). 
Processed food, high in fats and sugars, represents a major risk in high-income 
countries, promoting overweight and obesity (WHO, 2011). 
 The fourth risk factor listed is the harmful use of alcohol, which represents a 
major risk for premature deaths and disabilities in the world, and is responsible for 2.7 
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million deaths and 3.9% global DALYs (Lim et al., 2012). Harmful use of alcohol 
contributes to more than 60 types of diseases and injuries and there is a direct 
relationship between high levels of consumption and cancers. Furthermore 50% of 
deaths due to liver cirrhosis are attributed to alcohol. However, it is important to 
emphasize that the relationship between heart and cerebrovascular diseases and alcohol 
consumption is complex, because, until a certain level, alcohol consumption can have a 
protective effect (WHO, 2009).  
 For the high- and middle-income countries, the most important risk factors are 
those associated with heart diseases and cancer. Tobacco is one of the leading risks for 
both conditions: accounting for 11% of the disease burden and for 18% of deaths in 
high-income countries. 70% of the deaths caused by tobacco use occurred, however, in 
low- and middle-income countries. The prevalence of smoking is also higher in Central 
and Eastern Europe, and in parts of East and Southeast Asia (WHO, 2011). In 2010, 
smoking accounted for 8.4% of the worldwide disease burden among men (the leading 
risk factor) and 3.7% among women (Lim et al., 2012). For high-income countries risk 
factors such as alcohol, overweight and blood pressure are the leading causes of healthy 
life style losses, each being responsible for 6-7% of the total losses. The highest 
proportions of deaths attributed to alcohol were in Eastern Europe and Latin America 
(WHO, 2009). In addition, the high-income countries have the highest prevalence of 
other risk factors: physical inactivity among women, total fat consumption and raised 
total cholesterol (WHO, 2011). 
 The behavioral risk factors discussed above have an important role in the 
metabolic/physiological risk factors. The changes on diet and the increase on physical 
inactivity have contributed to increase the rates of overweight and obesity among 
people worldwide (WHO, 2009). High body mass index (BMI) is an important 
cardiovascular disease risk factor, and its effects are partly mediated by high blood 
pressure, cholesterol and glucose (Danaei, 2013).  
 Excess of salt intake, alcohol, sedentary life style and obesity, all have a role to 
play towards increasing blood pressure, in such a way that these factors “…have been 
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shown to be positively and progressively related to the risk for stroke and coronary 
heart disease” (WHO, 2011: 21). According to WHO (2009), these factors are 
responsible for 51% of strokes and 45% of ischaemic heart diseases. A more recent 
study reinforces their relevance for stroke, considering them as the most important 
mediators, accounting for two-thirds of the excess risk (Danaei, 2013). On the other 
hand, high intake of saturated fat, physical inactivity and genetics can increase 
cholesterol level, which is responsible, worldwide, for one third of ischaemic heart 
disease (WHO, 2009). The high blood glucose is also an important metabolic risk factor 
for cardiovascular diseases, causing all diabetes deaths, 22% of ischaemic heart disease 
and 16% of stroke deaths. Although genetics plays an important role in this risk factor, 
diet and physical activity are also relevant because adiposity increases the risk of 
diabetes (WHO, 2009; Danaei, 2013). 
 Blood pressure, considered as the most important mediator between BMI and 
cardiovascular disease, has decreased in high-income countries, such as Central Europe 
and parts of Latin America. Furthermore, serum cholesterol has decreased in western 
countries, but has increased in East and Southeast Asia (Danaei, 2013). High BMI has 
increased globally, presenting Australasia and Southern Latin America the highest 
values in this risk factor, with North Africa, Middle East and Oceania also ranking high 
in this risk factor (Lim et al., 2012).  
  In order to prevent and control NCDs the WHO proposed some main 
interventions, focused on the major behavioral risk factors, that even low- and middle-
income countries should be able to implement with health gains. Each of these 
interventions was called ‘best buy’ because it “is an intervention that is not only highly 
cost-effective4 but also cheap, feasible and culturally acceptable to implement” (WHO, 
2011: 47). Some of these ‘best buys’ are: protect people from tobacco smoke and ban 
smoking from public places; warn about the dangers of tobacco use; enforce bans on 
tobacco and alcohol advertising, promotion and sponsorship; raise taxes on tobacco and 
alcohol; restrict access to retailed alcohol; reduce the salt content of food; replace 
                                                           
4
 An intervention is considered highly cost-effective if, on average, it provides an extra year of healthy 
life (equivalent to averting one DALY) for less than the average annual income per person (WHO, 2011). 
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saturated fat with unsaturated fat and promote public awareness about diet and physical 
activity, through counselling in primary care (WHO, 2011). 
 The control and prevention of NCDs also include measures to improve the 
access to essential health care services, because it is important to carry out interventions 
to help people with disease or at high risk of developing disease. Furthermore, it is also 
important to take screening interventions for an early detection and treatment of 
cancers. At this level, some ‘best buy’ interventions are: counselling and multidrug 
therapy for people with 10-year risk of fatal or nonfatal cardiovascular event, cervical 
cancer screening and treatment of pre-cancerous lesions to prevent cervical cancer 
(WHO, 2011). A wide adoption of these interventions is expected to reduce the NCDs 
deaths by 2% per year, saving tens of millions of lives by 2020 (Beaglehole et al., 
2011). 
 However, all these modifiable and behavioral risk factors act with a background 
scenery, where socioeconomic factors, environmental and community conditions 
influence the risk of dying from NCDs. In this respect, people who have a low 
socioeconomic status or live in poor and marginalised communities have a higher risk 
of developing NCDs. Two of the socioeconomic factors identified as playing a 
background role in influencing health status are the level of income and the level of 
education (Di Cesare et al., 2013; WHO, 2009).  
 Therefore, poverty and the prevalence of NCDs are linked, people in vulnerable 
and socially disadvantaged conditions tend to get sicker and die sooner. Population in 
low- and middle-income countries are more exposed to common modifiable risk factors 
and an unhealthy behavior leads to a higher incidence of NCDs. Furthermore, these 
countries have limited access to effective and equitable healthcare services. At the 
household level, disability and premature death lead to a loss of household income, 
making families to get trapped in a vicious cycle where poverty and NCDs reinforce 
one another (WHO, 2011). 
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 The numbers are clear and policymakers have a central role on NCDs combat by 
developing and implementing appropriate strategies and action plans. In September 
2011, the United Nation High-Level Meeting on NCDs brought to discussion, at the 
highest level, priority actions and crucial interventions to combat the NCDs crisis, such 
as reducing risk factors and creating health-promoting environments. In addition, health 
systems should contribute to the combat of these diseases. As the WHO (2000b) 
defined, health systems have three main goals: first, to improve the health of the 
populations they serve; second, to respond to the reasonable expectations of those 
populations; and third, to provide financial protection against the costs of ill-health 
through fair contributions. Applying for these goals requires a two front response, one 
involves giving medical support to individuals with high risk or that already have the 
disease, and another comprehends public health interventions at population level and 
macroeconomic interventions (Strong et al., 2005). 
 The measurement of health system performance is a topic considered important 
by political international organizations because it “...seeks to monitor, evaluate and 
communicate the extent to which various aspects of the health system meet key 
objectives” (Smith et al., 2009a: 8). Health systems are very complex and have several 
stakeholders, including patients, various types of health-care providers, payers, 
purchaser organizations, regulators, government and the broader citizenry, each of them 
with different expectations and interests (Smith et al., 2009b). Performance 
measurement has an important role by enabling the different agents to have relevant 
information in order to make informed decisions and, through improved decision 
making, achieve their own goals. 
 Therefore, assessing the performance of a health system requires dealing with 
two issues: the first is how to measure the outcomes related with the health system’s 
goals (good health, responsiveness and fair financial contribution) and the second is 
how to compare those attainments with what the system should be able to achieve using 
the same resources (WHO, 2000b). 
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 International comparisons of health system performance are object of study from 
some of the most influent organizations, such as WHO and OECD. As emphasised by 
Veillard et al. (2009: 641) international benchmarking can be of great relevance for 
decision-making, considering that:   
 “The provision of comparative data presents vast methodological 
challenges but offers considerable potential for cross-country learning. 
Policymakers are looking for examples, benchmarks and solutions to 
address the pressures imposed by the epidemiological, economic, 
societal and technological demands on all European health-care 
systems.” 
 The World Health Report 2000 received much attention because it brought to 
discussion the importance of measuring the performance of health systems and outlined 
several initiatives to improve the perceived health situation in many countries. 
Notwithstanding criticisms to this study, it brought to discussion the importance of 
improving the data available so that more reliable cross-country studies could be done 
in order to improve the performance of health systems.  
 The limited resources available to prevent, treat and control the NCDs demands 
an efficient and effective health care delivery. In specific, efficiency is attained if the 
maximum benefits (outputs: goods or services) are obtained from the available 
resources (Smith, 2012), and effectiveness of care is attained if maximum desirable 
outcomes (health gains or equity) are obtained from a given level of outputs (Schinnar, 
1993). One can also define effectiveness in terms of resources used. In this respect, 
effectiveness of resources is attained if the maximum desirable outcomes are obtained 
from a given level of resources (Street and Häkkinen, 2009). A comparative analysis 
across countries in order to identify the best practices can contribute to improvements in 
health care policy and practice. This research explores the use of the DEA technique to 
assess the effectiveness of NCDs control and prevention in the OECD countries. 
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2.2. The use of DEA for health systems performance assessment 
 Farrell (1957) was the first author to present an empirical method to calculate the 
relative efficiency of several DMUs. This method uses data regarding the level of 
resources used (inputs) and the level of goods produced or services provided (outputs) 
to measure the relative efficiency of a set of decision making units (benchmarking). 
Farrell (1957) also suggested that efficiency consisted in two different components: 
technical efficiency, which reflects the ability to obtain the maximum output for a given 
set of inputs and the allocative or price efficiency that reflects the ability for using the 
set of inputs in optimal proportions given their respective prices and technology 
production (Coelli, Rao and Battese, 1998).  
 Farrell's empirical work had been confined to single-output cases when Charnes 
et al. (1978) extended his work and defined a linear program in order to obtain 
efficiency values, for a production system characterized by multiple inputs and multiple 
outputs. They also introduced an innovation to Farrell’s measure of efficiency. They 
introduced slack measures to account for non-radial adjustments to the frontier. 
According to the production metaphor used by DEA, each homogeneous DMU is 
engaged in a transformation process, where by using some inputs (resources) it is tries 
to produce some outputs (goods and services). DEA uses observed inputs and outputs in 
order to construct the production frontier. The relative efficiency is defined as the ratio 
of the total weighted output to the total weighted input (the ratio ranges from zero to 
one). A DMU is considered relatively efficient if it achieves a score of one. The 
technique allows each unit to choose the optimal weight structure in order to maximize 
the ratio. In addition, DEA allows each unit to identify a benchmarking group, in other 
words, a group of units that are following the same objectives and priorities, but 
performing better. There are two main advantages in adopting this technique, first it can 
handle multiple inputs and multiple outputs, and second it does not require a precise 
knowledge of the form of the production function. 
 DEA allows two types of orientation, input-oriented or output-oriented models. 
According to Coelli et al. (1998) in the input-oriented model the question to be 
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answered is: for a given set of outputs produced by a unit how much can the inputs be 
reduced maintaining the level of outputs? On the other hand, for the output-oriented 
models the question is: given a set of inputs, how much can the outputs be increased 
maintaining constant the level of inputs? To decide between these two orientations one 
must take into account the context under analysis and must identify which inputs and/or 
outputs are under the direct control of the DMUs. For example, if the DMUs have 
greater control over the inputs, then an input-oriented model should be used. It is also 
possible to use non-oriented models, which aim at a combination of input decrease and 
output augmentation.   
 The CCR model, also known as Constant Returns to Scale (CRS) model, 
measures the ratio of weighted outputs to weighted inputs subject to the condition that 
similar ratios for all DMUs under analysis are less or equal to unity. The mathematical 
formulation is: 
max h =	∑	uy ∕ ∑		v	x	     (1) 
subject to 
∑ uy ∑	v	x	⁄ ≤ 1	for	j = 1,… , n    (2) 
u, v	 ≥ 0	          (3) 
The y ,	x	  are the known outputs and inputs, respectively, of the jth DMU and the 
u, v	for all r and i, are the unknown weights to be determined by the solution of the 
problem. The constrain ∑ uy ∑	v	x	⁄ ≤ 1  reflects the condition that the virtual 
output ratio and the virtual input ratio of every DMU must be less or equal to unity. The 
weights used for each DMU are those that maximize the DMU’s efficiency score. 
However, this ratio of fractional programming above presented yields an infinite 
number of solutions, and it was necessary to transform it into a linear programming 
model for easier solution. The linearization can be done under two oriented model 
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perspectives (input or output). The linear programming CCR model with output-
orientation is represented by: 
minq =	∑ vx

       (4) 
subject to 
∑ u	y	
 
	 = 1				                    (5) 
∑ u	y!
 
	 /	∑ vx!

 ≤ 1						for k = 1, 2.....z          (6) 
u	, v ≥ 0					           (7) 
 The y!, x! represent the outputs and inputs for the industry, respectively, while 
	y	 and x represent the outputs and inputs for a given DMU. The output and input 
virtual weights are represented by u	y! and vx!, respectively, for the kth DMU. 
 Later, Banker, Charnes and Cooper (BCC) (1984) suggested that only DMUs 
with similar economic scale should be compared. They proposed an extension to the 
CCR model so that variable returns to scale (VRS) are considered. The output-oriented 
BCC model is formulated as follows: 
	#$%∑ &'
()'(
*
' + ,(     (8) 
subject to 
∑ -.
(/.( = 1
0
.              (9) 
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∑ &'
()'1/
*
' ∑ -.
(/.1 + ,( ≤ 1	234	5 = 1,… , 6
0
.    (10) 
  This model adds a constant variable, ,(, to the weight output (∑ &'()'(*' ) in 
order to permit variable (decreasing or increasing) returns to scale.  
 Since DEA was introduced in 1978, a great variety of DEA applications have 
been used to compare the performance of many different kinds of entities, activities and 
contexts (Liu et al., 2013). The electricity sector, banking, sports, marketing and 
agriculture are just some of these application fields.  
 The DEA technique has been widely used in the healthcare sector, considering 
that the comparative performance of a health system is of considerable interest for 
public management. Different levels of DMUs have been compared, although micro-
level analysis is far more common than macro-level analysis. Hollingsworth (2008) 
reviewed 317 references on frontier efficiency 5  in the context of health services 
delivery, concluding that analysis at the micro-level are far more common than macro-
level analysis, with the hospital as the most common unit of analysis. The efficiency 
measurement at a macro-level is undertaken in fewer studies to evaluate the 
performance of healthcare systems. Table 1A presented in Appendix 1 summarizes the 
characteristics of ten studies that have used DEA to compare health system performance 
across several countries. In this table we identify, for each of these studies, the type and 
number of units compared, the orientation chosen for the DEA model, the inputs and 
outputs chosen for analysis and the environmental variables included in the model. An 
analysis of the information presented in this table allows us to conclude that most of 
these studies have compared a sample of OECD countries, including the data available 
for several input, output and environmental variables. Examples of these macro-level 
studies are: Färe et al. (1997) who compared the productivity growth of a sample of 
countries; Puig-Junoy (1998) who measured the health production performance; 
                                                           
5
 There are two categories of methods for assessing efficiency: the parametric models, including classical 
regressions based in averages and stochastic frontier analysis (SFA) that uses econometric techniques and 
imposes a priori the functional form for the frontier and the distribution of efficiency and the non-
parametric models like DEA that relies on linear programming to obtain a benchmark of optimal cost and 
production-factor combinations. 
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Hollingsworth and Wildman (2003) who re-estimated the efficiency of health 
production of WHO panel data using parametric and non-parametric approaches to 
provide additional information; Retzlaff-Roberts et al. (2004) who analyzed the 
technical efficiency in the production of aggregated health outcomes; Bhat (2005) who 
examined the effects of various health care financing, regulatory and organizational 
designs on the efficiency of healthcare delivery systems; Afonso and Aubyn (2011) who 
assessed health efficiency across countries with a two-step and booststrap analysis and 
Hadad et al. (2013) who estimated healthcare system’s efficiency and analyzed the 
impact of health determinants on the efficiency score.  We will now discuss in greater 
detail the DEA applications that are of greatest relevance to our study in order to 
provide a summary of the state of the art in this area.   
 Although several studies have assessed the performance of healthcare systems, 
the assessment of the effectiveness of these systems has been very rare. Some 
exceptions include the studies by Schinnar et al. (1990) who estimate the organizational 
determinants of efficiency and effectiveness in mental health partial care programs and 
by Schinnar (1993) who investigated the tradeoffs between efficiency and effectiveness 
in management of public services and proposed effectiveness as a ratio of outcomes to 
service activities. For the latter author effectiveness is the ratio of outputs achieved to 
services provided in the second stage service production model. Amado and Dyson 
(2009) explored, in turn, the use of DEA for formative evaluation in primary diabetes 
care among English practices, taking into account different criteria for evaluation 
including technical, allocative and cost efficiency, clinical and patient-focused 
effectiveness, and equity. It is important to mention, however, that although no explicit 
reference is made to the effectiveness concept, there are several other studies that also 
assess the performance of healthcare systems through the use of outcome measures, 
such as infant mortality rates and life expectancy (e.g. Hadad et al., 2013; Afonso and 
Aubyn, 2011; Reatzlaff-Roberts et al., 2004 and Puig-Junoy, 1998). 
 To the best of our knowledge, a pioneering work on cross-countries healthcare 
system performance assessment was the one developed by Färe et al. (1997), which 
analyzed productivity growth for a sample of OECD countries from 1974 to 1989. 
These authors used DEA to estimate Malmquist productivity indexes and to decompose 
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productivity growth into efficiency change and technical change. This study was 
developed using two models, the first model used intermediate outputs (days and 
discharges) and focused on the hospital sector, the second model used health outcomes 
(life expectancy and infant mortality rate) and focused on the health system. 
 Later Puig-Junoy (1998) also used health outcome variables (male and female 
life expectancy at birth) as outputs in his study of health production performance in the 
OECD countries by using an input-oriented DEA analysis. This study estimated 
technical efficiency and decomposed it into its components of pure technical efficiency 
and scale efficiency. The author introduced some weight restrictions to make the results 
of the analysis meaningful. In particular, the restrictions imposed that on the side of the 
inputs the weight assigned to physicians must not be in any case lower than that of non-
physician personnel, and that on the side of the outputs the weight assigned to male life 
expectancy must not be greater than four times the weight of the variable female life 
expectancy. The author also used tobacco and alcohol consumption variables as life 
style proxies and a non-discretionary variable (the proportion of individuals under 65) 
as a proxy for age. The results from the study suggested that problems of inefficiency in 
the American and other healthcare systems may spring from allocative efficiency rather 
than technical efficiency. 
 The World Health Report 2000 (WHO, 2000b) presented a study developed by 
Evans et al. (2000) which used a panel data fixed effects models to estimate the 
technical efficiency and create a ranking of 191 countries. Hollingsworth and Wildman 
(2003) later reanalyzed the data with DEA (Malmquist productivity index) and 
Stochastic Frontier Analysis (SFA), having concluded that the league table presented in 
the World Health Report 2000 hided valuable information regarding efficiency changes 
over time. Furthermore, these authors emphasized that efficiency assessment is far more 
than ranking countries on a league table and that SFA and DEA techniques provide 
other useful information. The authors also alerted to the importance of sample 
stratification by GDP or geographical region. Alexander, Busch and Stringer (2003) 
took this suggestion into consideration on their efficiency assessment analysis of the 
healthcare systems of 51 developing countries by dividing the sample into two groups 
according to the countries’ GDP per capita. One group included the countries with a 
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GDP per capita less than $1500, and the other the countries with a GDP per capita 
between $1500 and $4500 per annum and three outputs (male disability adjusted life 
expectancy, female disability adjusted life expectancy and the infant mortality rate) 
were used in the first stage of the analysis. On the second stage of the analysis the 
authors used a regression model and found that health expenditure, literacy among 
women, access to health care services and essential drugs are positively related to 
greater efficiency of the healthcare systems. 
 To expand the previous international healthcare systems comparison Retzlaff-
Roberts et al. (2004) applied the DEA technique to explore the relationship between 
medical and social environmental inputs and health status outcome. The study 
implemented a comprehensive model including inputs regarding the social environment: 
school expectancy, the gini coefficient6 and tobacco use. The justification presented by 
the authors to use these variables were that education has a special role on determining 
health and is also associated with higher income, which allows the population to get 
better access to health care, housing and nutrition. In addition, they point out that 
unequal income distribution has an important effect on population health, representing a 
greater social environment challenge for improving population health. Finally, they 
argue that tobacco use is also an important variable to include in the analysis as it 
provides a measure for the lifestyle and behavioral choices of the population. Their 
study includes both input and output oriented DEA models allowing policymakers from 
each country to choose what suits them best, that is decreasing inputs or increasing 
health outcomes. The authors found that a country can be technically efficient or 
inefficient in its use of resources at any level of health outcome, for example, Mexico 
was found to be efficient in its use of health resources although needed urgent 
improvement in health outcomes. The authors also conclude that the USA can 
substantially reduce inputs while maintaining the current level of life expectancy. 
 Afonso and Aubyn (2011) have also contributed to this area of knowledge by 
regressing DEA scores on a set of explanatory variables, with a two-stage DEA/Tobit 
                                                           
6
 Gini coefficient is a measure of the degree of income inequality in a country. The values rage from 0 to 
1, and the higher the value is the greater the degree of inequality in the actual distribution of income 
(Retzlaff-Roberts et al, 2004). 
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and bootstrap procedures. In particular, they found that health inefficiency in OECD 
countries is related to GDP per capita, education level, obesity and smoking habits. In 
their work, in addition to the variables life expectancy and infant mortality rate they also 
used a transformation of PYLL as an output variable, which had been previously used in 
Afonso and Aubyn (2006). 
 The influence of non-discretionary variables on population health, that is 
variables over which policymakers have no or limited control, has been an important 
concern to researchers aiming to assess the performance of healthcare systems. Hadad et 
al. (2013) have explored this issue by estimating healthcare systems’ efficiency using 
two DEA models, one incorporating mostly inputs considered to be within the 
discretionary control of the healthcare system, and the other including mostly inputs 
beyond the short-term discretionary control of the healthcare system. Based on the 
results of their DEA models, they analyzed whether institutional arrangements, 
population behavior and socioeconomic or environmental determinants were associated 
with the healthcare systems efficiency. The results of this study showed that healthcare 
systems in nine countries with large and stable economies were defined as efficient by 
one model but were found to be inefficient by the other model. Therefore, the authors 
concluded that health system efficiency should aim to impact population behavior and 
welfare rather than only ensure adequate medical care.  
 Santos et al. (2012) also used some non-discretionary variables in their analysis 
aimed at exploring the use of DEA to assess the efficiency of mother-to-child HIV 
prevention in low- and middle-income countries. The results indicated that there are 
considerable variations across countries in the efficiency of preventive services, and 
also that DEA can have a potentially strategic role to assist an efficient and effective 
planning in this context. 
 From the discussion presented above we can conclude that whilst DEA has 
already been applied to assess the performance of healthcare systems, to the best of our 
knowledge, no studies have been documented on the use of DEA to compare countries 
effectiveness in preventing and controlling NCDs. An important departure of our study 
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from others is that, while previous studies have used aggregated health outcomes, ours 
focuses exclusively on outcomes related with the NCDs. This is a relevant contribution 
given that identifying the countries with best practices in this context can lead to 
meaningful learning regarding the most effective structures and processes associated 
with NCDs prevention and control. 
 Policymakers all over the world are concerned about the NCDs long-term 
macroeconomic impacts. However, research on the global economic effects of NCDs is 
still at an early stage (Bloom et al., 2011). The WHO (2011) refers that one of the three 
major components of NCDs surveillance is assessing health system capacity and 
response. Considering that our study aims to contribute to this assessment, it is timely 
and practically relevant. Its relevance is also reinforced by views expressed by the 
European Commission, which has pointed out that increasing the return on health 
investments requires a solid assessment of the efficiency and effectiveness of spending 
(Social Investment Package, 2013).  
 Whilst efficiency and effectiveness assessments in the health care context have 
been and will continue to be relevant, Spinks and Hollingsworth (2009) have pointed 
out a number of outstanding questions that limit the interpretation of the results and 
consequently their policy implications. Firstly, DEA assumes that the inputs that 
produce the health outputs are known with certainty. This assumption is unrealistic 
considering that there is great uncertainty about the set of inputs responsible for health 
production. Secondly, the DEA also assumes that inputs and outputs are isotonic, in 
other words, if the inputs increase the efficiency scores decrease and if the outputs 
increase the efficiency scores also increase. Thirdly, although the authors consider the 
OECD data base as one of the best cross-country sources of comparative data, some 
limitations still remain, such as: missing data; not all variables are collected regularly 
and no variables still exist to capture variations on genetics epidemiological which may 
influence the health outcomes within and between country comparisons. Considering 
these limitations, it is very important to exercise great caution when interpreting the 
results of health system performance cross-country comparisons.  
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 Our review of the literature allows us, therefore, to conclude that whilst cross-
country comparisons of the performance of healthcare systems are not new, there are 
not many studies carrying out this type of analysis. Furthermore, the few studies that 
exist tend to focus on high-level global health outcomes. To the best of our knowledge 
no study has been published documenting the effectiveness of nations in preventing and 
controlling NCDs, which are a leading cause of death worldwide and are a priority of 
many governments.  
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3. EMPIRICAL ANALYSIS 
3.1. The DEA model 
 The choice of appropriate input and output variables is a fundamental step in 
DEA analysis. The focus of this paper is to evaluate the effectiveness of OECD 
countries in preventing and controlling NCDs, with special relevance to the four main 
chronic diseases: cardiovascular, cancer, diabetes and respiratory disease. In this 
respect, the outputs of the model we propose below were chosen in accordance with this 
goal. 
 Having into account the main goal of this study and the methodological 
principles discussed in the previous section, we decided to use an output-oriented model 
with six discretionary inputs, one non discretionary input and four outputs. The output-
oriented model is the most appropriate since in this context it is preferable to maximize 
the health gains with the available resources, rather than keeping the health gains 
constant and minimizing the resources, as assumed in the input-oriented model. 
 To undertake the performance assessment on health system effectiveness with 
the DEA method some inputs have been used in most of the studies previously 
presented and seem to be widely accepted by the scientific community. In this respect, 
hospital beds, number of physicians, other health professionals, MRI units and total 
health expenditure represent some of those widely accepted inputs. On the other side, 
life expectancy and infant mortality are between the most commonly used outputs to 
assess health system efficiency. Researchers are aware that socioeconomic factors 
influence health outcomes. However, considering that these factors are beyond the 
direct control of the decision makers, they should be included as non-discretionary 
variables, wherein tobacco and alcohol consumption, income and education represent 
the more commonly non-discretionary variables used in this context. In the comparison 
undertaken in this study we have attempted to take into account all the methodological 
issues previously discussed. Furthermore, effectiveness measurement is especially 
complex due to the time lag between the inputs and the outcomes achieved. Also during 
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this time lag, as it was discussed on the previous chapter, the outcomes tend to be 
influenced by several variables that aren’t controlled by health services. In this sense, 
and for the reasons previously discussed, the results from comparisons of effectiveness 
across different health systems, although very important, should be interpreted 
cautiously.  
 The choice of inputs for this study follows what has been widely used in 
healthcare systems performance assessment with the DEA method. The prevention and 
control of NCDs in each country depends on access to the healthcare system (WHO, 
2011). The first three inputs in our model, “Practicing doctors per 100000 population”, 
“Practicing nurses per 100000 population” and “Hospital beds per 100000 population” 
are considered medical inputs to represent the access to healthcare, in consistency with 
the inputs included in several studies (Puig-Junoy, 1998; Retzlaff-Roberts et al., 2004; 
Afonso and Aubyn, 2011; Hadad et al., 2013). Access to the healthcare system is a first 
step to prevention and control of NCDs. We have also included the input variable 
“Magnetic resonance imaging units per 100000 population” and “Computed 
Tomography scanners per 100000 population” acknowledging the investment in and 
relevance of healthcare technology. These variables have also been broadly used in 
several studies in this field (Retzlaff-Roberts et al., 2004; Bhat, 2005; Afonso and 
Aubyn, 2011).  
 The sixth input is “Total current health expenditure per 100000 population 
(Million US$, Purchasing Power Parity7)” used as an input to provide a measure of a 
country’s preference for providing healthcare, (Mackenbach, 1991; Retzlaff-Roberts et 
al., 2004; Schwellnus, 2009; Spinks and Hollingsworth, 2009; Hadad et al., 2013). As 
Di Cesare et al. (2013) point out, this variable captures the financial and physical access 
to healthcare. The inclusion of this input is important because total spending in 
healthcare (at all levels) influences NCDs screening, diagnosis and treatment. 
 The prevention of premature mortality is a major goal, shared by the different 
health care organizations and countries, and is extensively discussed on NCDs action 
                                                           
7
 Purchasing Power Parities (PPP) are used to provide a comparable measure in the use of OECD data 
(Or, 2000). 
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plans (WHO, 2008). To capture the objective of avoiding premature deaths we 
considered the Potencial Years of Life Lost (PYLL)8 because it represents the number 
of lives lost before the age of 70 and that could be, theoretically, prevented. This is an 
acceptable variable as a health outcome indicator (Or, 2000) and has been used in some 
international studies with the DEA method (Afonso and Aubyn, 2011). However, unlike 
the studies that assess the health system as a whole, which use other outputs like life 
expectancy or infant survival rate, in our study we have only focused on PYLL from 
NCDs. As a result, we have only included PYLL of the four main groups of NCDs as 
outputs, according to what was previously presented in chapter 2. However, in a DEA 
model the outputs should be defined in such a way that ‘more is better’. In this respect, 
these variables were inverted in order to accomplish this principle. The output variables 
included are of the type 1/PYLL, so that, the smaller the number of years of life lost, the 
greater is the output value. The first output, “1/Diseases of the circulatory system years 
lost per 100 000 population, aged 0-69 years old”, includes the two main causes of 
premature death worldwide, ischaemic heart disease and stroke. The second output is 
“1/ Neoplasms years lost, per 100 000 population, aged 0-69 years old”. The third 
output is “1/ Diabetes Mellitus years lost per 100 000 population, aged 0-69 years old” 
and finally, the fourth output is “1/ Diseases of the respiratory system years lost per 100 
000 population, aged 0-69 years old”. 
 The socioeconomic pattern is known to have a relevant role on the level of 
population health. The most important NCDs behavioral risk factors are strongly 
influenced by income and education levels of the population, as several studies in this 
field suggest (Di Cesare et al., 2013; Hiscock et al., 2012; Pampel and Denney, 2011; 
McLaren, 2007; Kanjilal et al., 2006 and Monteiro et al., 2004). Therefore to capture 
the influence of these factors in our analysis we use the variable “Average number of 
years of education received by people aged 25 and older” as a proxy to education level, 
and as a non-discretionary input (Spinks and Hollingsworth, 2009; Afonso and Aubyn, 
2011; Santos et al., 2012). Di Cesare et al. (2013) reinforce the education role arguing 
                                                           
8 Potential Years of Life Lost (PYLL) is a summary measure of premature mortality which provides an 
explicit way of weighting deaths occurring at younger ages, which are, a priori, preventable. The 
calculation of PYLL involves summing up deaths occurring at each age and multiplying this with the 
number of remaining years to live up to a selected age limit (70 years old). The details are described at 
OECD Health Data 2013, Definitions, Sources and Methods: Potential years of life years lost by ICD 
categories available at: http://stats.oecd.org/index.aspx?queryid=30124. 
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that preventive actions, such as screening for breast, cervical, colorectal, and prostate 
cancers increase with education level and income level. The GDP per capita is also 
widely used as a proxy for the income level (Hadad et al., 2013; Schwellnus, 2009; 
Spinks and Hollingsworth, 2009). However, in this study we chose not to include this 
variable because, in our sample, there is a high correlation (98.5%) between the GDP 
per capita and the total health care expenditure per 100000 inhabitants. Table 3.1.1 
presents all inputs and outputs used in our DEA model.   
 
Table 3.1.1: DEA model to assess effectiveness of NCDs prevention and control  
 
 
3.2. Data and effectiveness results 
 The data used in this study refers to the activity of 27 OECD countries regarding 
NCDs prevention and control. The data refers to the year of 2009. In a minority of 
countries we had to use data from 2010 for some of the variables, due to non-
availability of data for 2009. We had to exclude 7 of the 34 OECD countries because of 
lack of available data. The data collected was extracted from trustworthy sources, 
mainly from the OECD database but also from the United Nations Development 
Programme. 
Inputs Outputs
Discretionary:
Input 1: Practicing doctors per 100000 population
Input 2: Practicing nurses per 100000 population Output 1: 1/Diseases of the circulatory system years lost per 100 000 population, aged 0-69 years old
Input 3: Hospital beds per 100000 population
Input 4: Magnetic resonance imaging units per 100000 
population
Output 2: 1/ Neoplasms years lost, per 100 000 
population, aged 0-69 years old
Input 5: Computed Tomography scanners per 100000 
population
Input 6: Total current health expenditure per 100000 
population (US$, PPP)
Output 3: 1/ Diabetes Mellitus years lost per 100 000 
population, aged 0-69 years old
Non-discretionary:
Output 4: 1/ Diseases of the respiratory system years 
lost per 100 000 population, aged 0-69 years old
Input 7: Average number of years of education received by 
people ages 25 and older
 28 
 
 Table 3.2.1 presents the summary statistics for the variables used. This table 
reveals some significant discrepancies among the 27 OECD countries compared. For 
example, whilst the average number of doctors per hundred thousand inhabitants is 321, 
this number almost doubles to 613 in Greece, whilst in Korea it is much lower with 192 
practicing doctors per hundred thousand inhabitants. The differences in the number of 
practicing nurses are also expressive among the countries, while Denmark, Belgium and 
Switzerland have more than 1500 practicing nurses per hundred thousand inhabitants, 
Mexico has the lowest number (109). The health expenditure also has an expressive 
variation, while Luxemburg is leading with almost 598 million US dollars per hundred 
thousand inhabitants followed by Switzerland (516 million), Mexico is at the bottom 
with 92 million, followed by Poland with 255 million. This variation is related with the 
country’s GDP, conditioning the resources available for health investment.  
 Considering that there are remarkable variations at the level of inputs, it is not 
surprising that we also find significant variations at the level of outputs. While 
Luxemburg and Slovenia are the countries with the lowest numbers of years of life lost 
due to diabetes and respiratory system diseases, respectively, Mexico has the highest 
PYLL in both groups. Finland and Israel have the lowest losses due to neoplasm and 
circulatory system diseases, respectively, and on the other side we find Hungary leading 
the PYLL on these two fields. 
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Table 3.2.1 – Data used in the DEA model 
 
Country
Practising 
doctors per 
100000 
population
Practising 
nurses per 
100000 
population 
Beds per 
100000 
population 
MRI units 
per 100000 
population  
 CT 
scanners 
per 100000 
population 
Total health 
expenditure per 
100000 population 
US$ PPP
Average 
number of 
years of 
education
1/PYLL due 
to Circulatory 
system 
diseases
1/PYLL due 
to Neoplasm
1/PYLL 
due to 
Diabetes
1/PYLL due 
to 
Respiratory 
system 
diseases
Input 1 Input 2 Input 3 Input 4 Input 5 Input 6 Input 7 Output 1 Output 2 Output 3 Output 4
Australia 310 1014 376 0,57 3,90 357296354 12 0,00253 0,00124 0,02242 0,00983
Austria 468 761 766 1,84 2,93 409813431 10,6 0,00225 0,00107 0,01905 0,01258
Belgium 292 1510 651 1,07 1,32 387440733 10,8 0,00205 0,00101 0,03247 0,00691
Czech Republic 356 806 711 0,57 1,41 197422387 12,5 0,00121 0,00087 0,02155 0,00500
Denmark 348 1544 349 1,54 2,37 422557663 11,3 0,00233 0,00102 0,01406 0,00741
Estonia 327 613 535 0,75 1,49 131479684 12 0,00072 0,00085 0,01305 0,00512
Finland 271 958 625 1,57 2,04 308567342 10,2 0,00153 0,00136 0,02174 0,01196
France 310 845 666 0,64 1,11 381577787 10,4 0,00267 0,00089 0,03279 0,01250
Germany 364 1103 824 1,03 1,77 403457534 12,2 0,00184 0,00105 0,02667 0,00898
Greece 613 331 485 2,17 3,38 293084576 10,1 0,00138 0,00108 0,05988 0,00633
Hungary 302 621 714 0,28 0,72 153299461 11,6 0,00069 0,00052 0,01258 0,00409
Iceland 365 1454 373 2,19 3,45 359609692 10,3 0,00241 0,00120 0,04808 0,01364
Ireland 274 1526 327 1,19 1,53 388366019 11,6 0,00194 0,00102 0,03236 0,00953
Israel 346 473 335 0,20 0,94 193095893 11,9 0,00350 0,00125 0,01357 0,01067
Italy 368 630 363 2,12 3,13 288179464 10 0,00255 0,00108 0,02717 0,01490
Korea 192 447 821 1,88 3,68 180128762 11,5 0,00265 0,00113 0,01379 0,01401
Luxembourg 270 1112 547 1,41 2,61 597653582 10 0,00256 0,00119 0,09709 0,00840
Mexico 205 247 167 0,19 0,43 91599590 8,4 0,00132 0,00128 0,00154 0,00225
Netherlands 292 836 466 1,09 1,13 451193499 11,5 0,00241 0,00097 0,02513 0,00933
New Zealand 257 970 240 0,97 1,46 298378504 12,4 0,00195 0,00106 0,01471 0,00657
Poland 217 525 665 0,37 1,24 126353124 9,9 0,00082 0,00075 0,01805 0,00495
Portugal 382 565 335 0,92 2,74 254874175 7,6 0,00244 0,00092 0,01946 0,00675
Slovak Republic 299 603 651 0,61 1,33 194183465 11,6 0,00081 0,00076 0,02315 0,00325
Slovenia 241 802 460 0,69 1,18 229978138 11,7 0,00196 0,00088 0,04255 0,02083
Spain 354 493 319 1,07 1,50 299194552 10,2 0,00246 0,00101 0,04525 0,00747
Switzerland 383 1520 510 1,78 3,28 515662013 10,9 0,00300 0,00129 0,04566 0,01742
United Kingdom 271 997 334 0,59 0,82 326112005 9,3 0,00182 0,00108 0,03831 0,00539
Mean 321 863 504 1,09 1,96 305205905 10,8 0,00199 0,00103 0,02897 0,00911
Standar-deviation 85 386 185 0,62 1,02 124478971 1,2 0,00073 0,00019 0,01911 0,00448
Maximum 613 1544 824 2,19 3,90 597653582 12,5 0,00350 0,00136 0,09709 0,02083
Minimum 192 247 167 0,19 0,43 91599590 7,6 0,00069 0,00052 0,00154 0,00225
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 In order to assess each country’s effectiveness, we used the Efficiency 
Measurement System (EMS) Version 1.3 software (Scheel, 2000) and an output-
oriented DEA model. We have used the formulation proposed by Banker, Charnes and 
Cooper (1984), also known as the BCC model, in consistency with the advice of 
Hollingsworth and Smith (2003). In this publication, Hollingsworth and Smith (2003) 
warn that when ratio measures are included in the DEA model, the CCR model 
(Charnes et al, 1978) is technically incorrect and the BCC formulation (Banker et al., 
1984) should be adopted. According to Hollingsworth and Smith (2003), the BCC 
formulation assures that comparison of the DMUs is made by interpolation only, ruling 
out unfeasible extrapolations.  
 We included seven weight restrictions in the effectiveness model, in order to 
ensure meaningful results and to account for production trade-offs between inputs and 
outputs (Podinovski, 2004). The weight restrictions included were the following:  
71 ≥ 72  (Restriction 1) 
72 ≥ 74  (Restriction 2) 
72	 ≥ 75  (Restriction 3) 
72 ≥ 73  (Restriction 4) 
76 ≥ 75  (Restriction 5) 
76 ≥ 73  (Restriction 6) 
76 ≥ 77  (Restriction 7) 
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 Our main concern was to ensure meaningful results. In this respect, the 
restrictions aim to establish meaningful production trade-offs between the inputs and 
were defined according to Podinovsky (2004) methodology. The first restriction states 
that the weight attributed to the number of doctors cannot be inferior to the weight 
attributed to the number of nurses. We are assuming that, if necessary, the work carried 
out by a nurse could also be carried out by a doctor, but the reverse is not plausible. The 
inclusion of this restriction is in line with the study by Amado and Santos (2009) 
regarding performance assessment and improvement in primary health care. In our work 
this restriction is also relevant, taking into account that important skills, like prescribing 
medication or complementary diagnostic examinations, are essential to accomplish an 
important part of the ‘best buys’ defined by WHO (2011) and are exclusive to doctor’s 
skills.  
 The second and third restrictions state that the weigh attributed to the number of 
nurses cannot be inferior to the weight given to the number of MRI units and CT 
scanners, respectively. These restrictions assure that the health care professionals have 
more relevance to the control and prevention of the NCDs than complementary 
diagnostic examinations since those have to be prescribed, carried out and assessed by a 
health care professional. It is also widely recognized that human resources are a central 
and fundamental piece of health systems (Narasimhan et al., 2004; Hongoro and 
McPake, 2004; Dussault and  Dubois, 2003).  
 The fourth restriction goes along with the arguments presented above. It states 
that the weight given to the number of nurses cannot be lower than the weight attributed 
to the number of hospital beds. In our study the number of hospital beds is a proxy for 
the infrastructures available that determine access to healthcare. In this respect, we 
argue that the weight attributed to this proxy should not be superior to the weight 
attributed to the number of doctors and the number of nurses, which are fundamental to 
achieve good results in NCDs prevention and control. 
 The last three restrictions are related to the relevance of the health care 
expenditure. Those restrictions state that the weigh given by each country to the health 
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Country Score (%)
    Australia 96.43
    Austria 83.34
    Belgium 80.14
    Czech Republic 74.90
    Denmark 79.24
    Estonia 83.79
    Finland 100.00
    France 91.01
    Germany 79.62
    Greece 100.00
    Hungary 55.82
    Iceland 100.00
    Ireland 81.47
    Israel 100.00
    Italy 95.16
    Korea 100.00
    Luxembourg 100.00
    Mexico 100.00
    Netherlands 80.19
    New Zealand 84.52
    Poland 100.00
    Portugal 81.60
    Slovak Republic 72.85
    Slovenia 100.00
    Spain 100.00
    Switzerland 100.00
    United Kingdom 87.05
Mean 89.15
Standard-deviation 11.64
Maximum 100.00
Minimum 55.82
care expenditure cannot be inferior to the weights attributed to the number of CT 
scanners, hospital beds and the level of education received, respectively. Health care 
expenditure influences health care delivery trough the access to hospital beds, medical 
staff and new technology (OECD, 2011). Total health care expenditure is related to 
health outcomes and several studies have revealed that countries that spent little on 
health care also have poorer health conditions (Poullier et al., 2002; Farag et al., 2013). 
In other words, a higher country’s health care expenditure is significantly associated 
with large improvements in health outcomes (Nixon and Ulmann, 2006). 
 Having justified the variables used in our model, we will now present and 
discuss the results obtained for our sample of 27 OECD countries. Table 3.2.2 presents 
the effectiveness scores obtained as a result of our analysis. 
Table 3.2.2 – Effectiveness scores obtained with DEA 
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 Table 3.2.2 reveals that 11 countries out of the 27 are classified as effective in 
preventing and controlling NCDs. The effective countries are: Finland, Greece, Iceland, 
Israel, Korea, Luxemburg, Mexico, Poland, Slovenia, Spain and Switzerland. The 
average score is of 89.15% and there are 5 countries with effectiveness scores under 
80%: Czech Republic, Denmark, Germany, Slovak Republic and Hungary. 
 For a better understanding of the results obtained it is important to identify the 
optimal weight structure chosen by each country. The virtual weight profile can provide 
some useful information about the strategy followed in each country to prevent and 
control NCDs. 
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Practising 
doctors per 
100000 
population
Practising 
nurses per 
100000 
population 
Beds per 
100000 
population 
MRI units 
per 100000 
population  
 CT 
scanners 
per 100000 
population 
Total health 
expenditure 
per 100000 
population 
US$ PPP
Average 
number of 
years of 
education
1/PYLL due to 
Circulatory 
system 
diseases
1/PYLL due to 
Neoplasm
1/PYLL 
due to 
Diabetes
1/PYLL due 
to 
Respiratory 
system 
diseases
Input 1 Input 2 Input 3 Input 4 Input 5 Input 6 Input 7 Output 1 Output 2 Output 3 Output 4
    Australia 1 0 0 0 0 0 0 0.14904 0.83661 0.01435 0
    Austria 0 0 0 0 0 0.78 0.22 0.04704 0.65245 0 0.30051
    Belgium 1 0 0 0 0 0 0 0.17884 0.80444 0.01672 0
    Czech Republic 0.14117 0 0 0 0 0.85883 0 0.01517 0.73048 0.20232 0.05202
    Denmark 1 0 0 0 0 0 0 0.12819 0.87181 0 0
    Estonia 0 0 0 0 0 1 0 0 0.45831 0.50784 0.03384
    Finland 1 0 0 0 0 0 0 0 0.90725 0 0.09275
    France 0.81842 0.10726 0 0.0075 0.0066 0.04642 0.0138 0.65097 0 0.10022 0.24881
    Germany 0.00012 0.00006 0 0.00001 0.00001 0.9998 0 0.07029 0.86761 0.0621 0
    Greece 0 0 0 0 0 0.72686 0.27314 0 0 1 0
    Hungary 0 0 0 0 0 1 0 0.09886 0.26792 0.63322 0
    Iceland 0 0 0 0 0 0.762 0.238 0.04071 0.60209 0.19881 0.15838
    Ireland 1 0 0 0 0 0 0 0.16238 0.78095 0.02161 0.03506
    Israel 0 0 0 0 0 1 0 1 0,00000 0 0
    Italy 0 0 0 0 0 0.72548 0.27452 0.04607 0.60072 0.04316 0.31005
    Korea 1 0 0 0 0 0 0 0.00051 0.00293 0.95883 0.03773
    Luxembourg 1 0 0 0 0 0 0 0 0 1 0
    Mexico 0.63699 0.13766 0.03066 0 0.01732 0.08869 0.08868 0.67679 0.16966 0.03136 0.12219
    Netherlands 1 0 0 0 0 0 0 0.20223 0.7466 0.01681 0.03436
    New Zealand 1 0 0 0 0 0 0 0.16637 0.82622 0.00741 0
    Poland 0 0 0 0 0 1 0 0 0 1 0
    Portugal 0 0 0 0 0 0.75462 0.24538 0.64466 0 0.35534 0
    Slovak Republic 0.06698 0 0 0 0 0.93302 0 0 0.32308 0.67692 0
    Slovenia 0.17903 0.10704 0.02026 0.00841 0.01124 0.67401 0 0 0 0.56703 0.43297
    Spain 0.00633 0.00158 0.00034 0 0.00034 0.72273 0.26868 0.44624 0 0.55376 0
    Switzerland 0.55435 0.23528 0.00703 0.01061 0.00263 0.16693 0.02318 0.27576 0.32773 0.07725 0.31926
    United Kingdom 0 0 0 0 0 0.76279 0.23721 0.03131 0.74327 0.19256 0.03286
Table 3.2.3 – Virtual weight attributed to the variables by the countries  
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 Table 3.2.3 reveals that the virtual weights given to the four outputs differ across 
the countries. While some countries gave all the weight to one output, such as Greece, 
Israel, Luxemburg and Poland, other countries distributed the weight between two or 
more outputs. It is also interesting to see that those countries which attributed total 
weight to a single output are among the group of effective countries. However, it is 
important to emphasize that there may exist alternative optimal solutions for the input 
and output weights of the countries classified as best performers (Cooper, Ruiz and 
Sirvent, 2007). In this respect, it is possible that the attribution of more balanced weight 
profiles to these effective countries would continue showing them as effective. The 
remaining effective countries distributed the weight unequally between outputs. It is 
interesting to see that 13 countries put more than 50% of the weight in PYLL due to 
neoplasm diseases, although none of them put all the weight on this variable. The 
second output most valued was PYLL due to diabetes, with Greece, Luxemburg and 
Poland giving it the total weight. PYLL due to respiratory diseases was the output least 
valued by the countries, where Slovenia attributed the highest value (43.3%). 
 The optimal input weight profiles are presented in Table 3.2.3. However, to 
discuss these weights it is important to recall that some weight restrictions were 
imposed to ensure meaningful results. Unlike what happened in terms of the choice of 
virtual output weights, some of the non-effective countries attributed the totality of the 
weight to a single input, such as Australia, Belgium, Denmark, Estonia, Hungary, 
Ireland, Netherlands and New Zealand. In consistency with what was imposed in the 
weight restrictions, the number of practicing doctors and the total health expenditure 
were the two inputs which received a full weight in the evaluation of these non-effective 
countries. Among the countries classified as effective, there were 5 that attributed the 
full weight to one of the referred inputs, these countries were: Finland, Israel, Korea, 
Luxemburg and Poland. Greece and Iceland have a similar input weight profile, 
distributing their weight between total health expenditure and average level of 
education. In contrast, the remaining effective countries, Mexico, Slovenia, Spain and 
Switzerland present a balanced weight profile, distributing the weight between at least 
six inputs. It is also worth noticing that the environmental variable was chosen by 10 
countries, assuming a relative weight between 22% and 27% in the majority of these 
countries. 
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 Another interesting piece of information provided by DEA relates with the 
identification of benchmarks for each of the ineffective countries. Benchmarks are units 
that are classified as effective when applying the optimal weight structure of the 
ineffective units under analysis. As we can see in Table 3.2.4, Israel and Finland are the 
countries that could serve as benchmark to the highest number of ineffective countries. 
In the particular case of Finland, this country could be used as a reference to Australia, 
Austria, Belgium, Denmark, Germany, Ireland, Italy, Netherlands, New Zealand and 
United Kingdom. DEA results also identify from which countries the nations with poor 
effectiveness scores can learn with. For example, the two countries with the lowest 
scores, Hungary and Slovak Republic, can learn from Greece, Mexico, Poland and 
Slovenia. Also the Netherlands and New Zealand share as benchmarks Finland, Israel, 
Korea and Luxemburg. The appropriateness in the benchmarks identified by the model 
can be evaluated through a detailed analysis of the structures and processes of health 
care provision in each country. In specific, observing their weight profiles, it is clear 
that Hungary and Slovak Republic, in one hand, and the Netherlands and New Zealand, 
in the other, have many commonalities in their NCDs prevention and control policies.  
 In addition to the information regarding the benchmarks from which the 
ineffective countries can learn, Table 3.2.4 provides useful information to define the 
targets to be achieved by these countries. This information is contained in the lambda 
values displayed in each of the rows of table 3.2.4. For example, the values of the 
lambdas associated with Hungary (0.087; 0.253; 0.455 and 0.204) represent the 
proportion of the outcome levels of Greece, Mexico, Poland and Slovenia required if 
Hungary wants to achieve effective levels of PYLL in each of the four groups of NCD 
conditions.
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Table 3.2.4 – Peers and lambdas  
Finland Greece Iceland Israel Korea Luxembourg Mexico Poland Slovenia Spain Switzerland
    Australia 0.40719 0.50666 0.06986 0.01628
    Austria 0.23198 0.1268 0.06015 0.58107
    Belgium 0.31705 0.34277 0.04868 0.2915
    Czech Republic 0.3161 0.05112 0.06607 0.01504 0.44966 0.10202
    Denmark 0.17887 0.39609 0.42505
    Estonia 0.03385 0.4537 0.36528 0.14717
    Finland
    France 0.39016 0.11068 0.13419 0.15683 0.20814
    Germany 0.48346 0.04097 0.01385 0.46171
    Greece
    Hungary 0.08737 0.25307 0.45522 0.20434
    Iceland
    Ireland 0.3498 0.13331 0.1926 0.24981 0.07447
    Israel
    Italy 0.05346 0.24158 0.22658 0.27435 0.20403
    Korea
    Luxembourg
    Mexico
    Netherlands 0.03703 0.45315 0.25929 0.18209 0.06845
    New Zealand 0.45126 0.19204 0.35595 0.00075
    Poland
    Portugal 0.10382 0.70757 0.18861
    Slovak Republic 0.1894 0.33393 0.01485 0.46182
    Slovenia
    Spain
    Switzerland
    United Kingdom 0.02581 0.0246 0.10192 0.41429 0.43338
Number of times 
country i used as a 
peer
10 5 2 13 7 9 5 3 7 0 8
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 Whilst some countries serve as a benchmark to a large number of countries, such 
as for example, Finland and Israel, others are classified as effective but serve as a 
reference for very few countries, like Iceland and Poland. And more peculiar is the case 
of Spain that is considered effective but that does not serve as a benchmark for any 
country, which may be a result of its atypical weight structure. Since there are countries 
such as Israel and Finland which serve as a benchmark to 13 and 10 countries, 
respectively, it is very important to understand their strategies, structures and processes 
in this field, in order to provide guidance for other countries.  
 
3.3. The practical and policy implications of the results 
 The information obtained from the results previously presented shows that there 
is potential for countries to improve their policies on NCDs prevention and control, 
learning from the experiences of other countries. Improvements in this area could save 
many lives and avoid premature deaths. The results can constitute a valuable 
information source to policymakers, programme planners, managers and health care 
professionals. The aim of this study is not to establish ranks between the countries but 
to identify best practices on NCDs prevention and control, in order to develop strategies 
and policies that have the potential to make healthcare systems more effective in 
handling this type of diseases.  
 As a result of our analysis two countries appear as important benchmarks to 
other nations, Israel and Finland. These two countries, according to our DEA analysis, 
constitute a benchmark for 10 countries in common: Australia, Austria, Belgium, 
Denmark, Germany, Ireland, Italy, Netherlands, New Zealand and United Kingdom. 
However, Israel is also a benchmark to Czech Republic, France and Portugal. 
Nevertheless, these two countries appear to follow different strategies to prevent and 
control NCDs. Whilst Israel was the only country to put the full weight on 
cardiovascular diseases, Finland has a weight profile that indicates that it has valuable 
experience to share on Neoplasm’s prevention and control. Hereafter, we will discuss 
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some of the strategies developed and implemented by these two countries which can be 
an inspiring model to some of the non-effective countries, especially to those to which 
they serve as a reference. 
 Israel is between the OECD countries with the lowest ischaemic heart disease 
mortality rate and in 2009 presented the lowest stroke mortality rate along with a low 
admission rate for uncontrolled diabetes (OECD, 2011). The actions taken on the 
modifiable risk factors have contributed to these health gains, for example, a notable 
decline in tobacco consumption and an improvement on the level of control on 
hypertension, both known as important modifiable risk factors for stroke (WHO, 2012). 
Israel also has one of the lowest rates of alcohol consumption across European 
countries, although this may also be related to culture and religious options. As 
discussed in the literature review section, diet is another important life style factor on 
cardiovascular diseases and Israel has remarkable results on fruit and vegetables 
consumption, being far above the European average and far above the average for the 
countries participating in the EPA-cardio programme9(Lieshout, Wensing and Grol, 
2008). 
 Israel achievements on cardiovascular diseases outcomes is particularly related 
to the high standard of primary care and all the policies that have been implemented in 
the last decades in this field (Lieshout et al., 2008; OECD, 2012). In addition, Israel is 
one of the OECD countries with the lowest level of health care expenditure. Whilst 
most countries have increased their health care expenditure, Israel has built a high 
quality primary care under tight budgetary circumstances (OECD, 2012). The results 
obtained with our DEA analysis corroborate these reports. The optimal weight profile of 
Israel shows that this country benefited from putting all its input weight on total health 
care expenditure and all its output weight on cardiovascular diseases.   
                                                           
9
 EPA-cardio programme concerns an international study of cardiovascular risk management in primary 
care in 10 European countries. Its aim is to provide insight into the current services delivered in primary 
care to prevent cardiovascular diseases, as well as to inform and support primary care practices, national 
health policies and decision makers in this domain. 
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 In this particular field, the success of Israel is based on an effective primary 
health care service delivery, which takes advantage of the proximity to the population to 
implement prevention strategies and control measures. According to the OECD (2012) 
report a distinctive aspect on Israel primary care is the fact that the medical teams are 
set on community-based health clinics allowing the person to access a broad range of 
health expertise and support, such as regular monitoring of a patient’s health indicators, 
delivering follow-up support and tailoring preventive advice to the specific needs of the 
communities. They also provide care 24 hours a day through telephone lines, evening 
care centers, urgent care centers and home visit services. The patients suffering from 
chronic diseases are likely to find a healthcare professional (doctor or nurse) working to 
help them monitor their health condition, such as measurement of blood pressure and 
blood glucose for those suffering from diabetes, also known as a major risk factor for 
cardiovascular diseases (WHO, 2012). Team working seems to have an important role 
in these achievements. OECD publications reinforce that even in countries like the 
United Kingdom, Australia and New Zealand, with strong primary health care history, 
professionals are not working as a team, with a large proportion of doctors continuing to 
work isolated. According to the OECD report on Israel health care delivery (OECD, 
2012), it is well established that health care teams are a distinctive asset allowing 
community health clinics to support patient with chronic diseases with strategies such as 
follow-up after a visit, routine health screening and proving advice on improving 
lifestyle. Other strength in Israel service delivery relies on an effective technology 
platform which reminds health care professionals about which patients have not 
received a regular check-up. This platform also allows the collection of an extensive 
range of data integrated with the Quality Indicators in Community Health Care 
programme. This platform provides basic patient demographics and thirty five measures 
across six key areas that include cardiovascular health, allowing the identification of 
some risk factors, the monitoring of quality of care delivery, the monitoring of drug 
utilization and the measurement of selected treatment outcomes. 
 The second example of success in preventing and controlling NCDs is offered by 
Finland and, according to its weight profile, it seems that this country has developed 
some effective interventions on cancer prevention and control. As discussed in the 
literature review section, it is well established that smoking is a major risk factor for 
cancer, in particular for lung cancer (Danaei et al., 2005). Furthermore it is known that 
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lung cancer presents the highest mortality rate among men worldwide (Lozano et al., 
2012). Finland has one of the lowest lung cancer mortality rates (Ferlay et al., 2013) and 
also one of the lowest global cancer mortality rates in 2009 across the OECD countries 
(OECD, 2011). Behind these good health outcomes may be the strong investment in 
tobacco control and an extensive screening programme. According to the Tobacco 
Control Scale (TCS) 2010 in Europe, Finland is the 5th ranked country in TCS score 
taking in consideration our sample of countries and the 6th higher investor among the 31 
European countries, investing 0.28€ per person in 2009 for tobacco control. However, it 
has not always been like this, and forty years ago Finland was between the highest 
consumers of tobacco products when it decided to implement policies to decrease the 
number of daily smokers. As a result of these policies, after achieving a pick in the 70s, 
the rates of lung cancer in males in Finland have been decreasing since then. Finland 
was a pioneer to stipulate in law that it aims to end the use of tobacco products 
containing compounds that are toxic to humans and create addiction. The path taken by 
this country shows that a significant decrease in smoking prevalence and premature 
deaths can be achieved through tax increases, a high-intensity media campaign 
complemented with encouragement and treatment cessation programmes, stronger 
health warnings and enforcement of youth access laws (Levy et al., 2012). 
Observing the Eurobarometer on tobacco (European Commission, 2010), implementing 
legislative actions and health promotions campaigns can change the population 
behavior. According to the data revealed in Eurobarometer on tobacco, the Finnish are 
the least permissive of smoking inside the house and have tight legislation in public 
indoor smoking and this is also one of the countries in favor of banishing the advertising 
of tobacco products in points of sales. Today, in Finland, smoking is considered to be 
primarily a public health, social and political issue. Since 1995 that smoking was 
restricted by law in such a way that no employee can be exposed to tobacco smoke 
against a person’s will. Furthermore, the age limit for selling tobacco products increased 
to 18 years old and indirect tobacco advertising and sponsoring was forbidden Cancer 
Society of Finland (2013). 
 Finland also has the highest breast screening rate (over 80% according to OECD, 
2011). This country established some strong screening policies in order to deal with this 
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major disease. Population-based mass screening is considered a crucial part for cancer 
control according to Finnish authorities. Besides breast cancer screening also cervical 
and colorectal cancer screening are widely carried out. Finnish Cancer Registry 
maintains a database on the screenings to evaluate their programmes including quality 
standards. These two major strategies are recognized by Hurtado, Swift and Corrigan 
(2001) who defend that high quality health care in the case of cancer include effective 
screening and early diagnosis programmes.  
 These two countries have in common a primary care sector broadly developed, 
that seems to be a major factor for the results achieved by each country. These results 
go in line with the findings suggested by Macinko, Starfield and Shi (2003) who 
suggested that countries with larger proportion of primary health care services 
potentially have more efficient and effective health systems. 
 The results obtained with our study illustrate the potential of the DEA 
methodology to measure, analyze and promote improvement in the context of NCDs 
prevention and control. Using this technique, policymakers and health care managers 
can identify which countries have been most successful in this area. Further to the 
identification of best practices, DEA results can prompt policymakers and managers to 
study these systems’ structures and processes with the intention of adapting them to the 
contexts of the countries that need improvement.  
 Although our empirical analysis covers a single year and focuses exclusively on 
a limited number of countries, the results obtained provide useful information for policy 
making by identifying best performers and discussing some of the policies that have 
proved successful in some of these best performers. Further exploratory analysis of this 
type can contribute to the improvement of NCDs prevention and control.  
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4. CONCLUSION 
 NCDs are the leading global cause of deaths, wherein cardiovascular diseases, 
cancer, chronic respiratory diseases and diabetes are the main NCDs responsible for 
more than 65.5% of all deaths worldwide. A substantial amount of the NCDs are 
attributable to behavioral, dietary, environmental and metabolic risk factors. The fact 
that a great percentage of premature deaths can be prevented has attracted the attention 
of decision makers to the importance of implementing affordable interventions to 
prevent, control and treat these diseases. In this context the WHO presented the ‘best 
buy’ interventions that the healthcare systems should target at the individuals that are at 
risk of developing or that already have NCDs. This epidemic also has a high 
socioeconomic impact since premature deaths and disability have a negative impact on 
the productivity and consequently on the development of a nation. The burden of NCDs 
also causes impoverishment of the families, raises the health care systems costs and 
contributes to economic decline. 
 In the academic literature there have been important contributions exploring the 
use of DEA to assess the efficiency of healthcare systems across-countries. However, 
most of these studies focused on the healthcare system a whole, using health outcomes 
such as life expectancy and infant mortality. No distinction was made on these studies 
to particular diseases. In this dissertation, we have explored the potential of using DEA 
to complement the existing literature in the area. In particular, we have focused on the 
effectiveness rather than on the efficiency of the countries in implementing prevention 
and control policies targeted at a particular type of diseases – the NCDs. To this effect, 
we used data for 27 OECD countries for the year 2009. 
 Despite the exploratory nature of this research, there are some empirical findings 
that we consider relevant. In particular we identified 5 OECD countries with 
considerable potential for improvement in this area. These countries are Czech 
Republic, Denmark, Germany, Slovak Republic and Hungary. Additionally, our post 
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evaluation analysis also identified some valuable insights that can assist these and other 
countries to implement more effective NCDs prevention and control policies. In order 
for a proper set of guidelines to be drawn to assist performance improvement in this 
context, it would be valuable, however, to carry out more extensive assessments. 
 Although the use of DEA has potential in this context, its formative 
implementation faces some challenges. As many other authors have referred, the lack of 
availability of data and the poor quality of some of the data available is perhaps the 
most relevant challenge. More reliable and available data would allow, not only the 
development of more informative models, but also the development of dynamic 
assessments. Furthermore, if data was available this type of analysis could be extended 
to other countries, including low- and middle-income countries.  
 Another issue that requires further research is related with the development of 
weight restrictions in order to ensure meaningful results. Although several studies have 
been carried out in the health care context, research on how to express weight 
restrictions that are valid and derive from the preferences of the stakeholders is still 
scarce. 
 In spite of these challenges, we believe that the DEA technique can provide very 
valuable information to assist nations improve their performances regarding the 
prevention and control of NCDs.  
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Study DMUs DEA orientation Inputs Outputs Environmental variables
Fare et al. (1997) 19 OECD 
countries
Input and output-
oriented
1.Number of physicians                     
2.Number of medical care beds
Model I:                                             
1.Inpatient days                    
2.Number of discharges                            
Model II:                                            
1. Life expectancy of women at age 
40                                                   
2.Infant survival rate
Puig-Junoy, J. (1998) 21 OECD 
countries
Input-oriented 1.Number of physicians                     
2.Number of nonphysician personnel                                          
3. Number of hospital beds 
1.Male life expectancy at birth              
2.Female life expectancy at birth. 
1.Tobacco consumption                        
2.Alcohol consumption               
3.Proportion of individuals under 
65 
Hollingsworth and Wildman (2003) 140 WHO 
countries
Output-oriented 1.Health expenditure per capita 
(US$, PPP)                                     
2.Average years of schooling in the 
adult population
1.Disability adjusted life expectancy    
Alexander et al. (2003) 51 developing 
countries
Output-oriented 1.Health expenditure per capita 
(US$, PPP)
1.Male disability adjusted life 
expectancy                          
2.Female disability adjusted life 
expectancy                            
3.Infant mortality subtracted from 
1000
Variables used in Tobit regression:                       
1.Health expenditure                                   
2.Female literacy rate    
3.Proportion of the population 
regarded as undernourished   
5.Coverage of measles 
immunization rate               
6.Number of doctors           
7.Proportion of the population 
with access to essential drugs     
8.Proportion of the adults living 
with AIDS
Retzlaff-Roberts, D.(2004) 27 OECD 
countries
Input and output-
oriented 
1.Number of inpatient beds                  
2.Number of MRI units                      
3.Number of Physicians                            
4.Health expenditure (US$, PPP) 
1a.Infant survival rate                                   
1b.Life expectancy at birth      (the 
outputs were used separately)
1.School expectancy                                       
2.Gini coefficient                     
3.Tobacco use
Bhat, V.N. (2005) 24 OECD 
countries
Input-oriented 1.Number of  physicians  2.Number 
of nurses                                
3.Number of inpatient beds                  
4.Volume of pharmaceuticals 
consumptions (US$, PPP)
1.Population aged 0–19 years          
2.Population aged 20–64     
3.Population aged 65 or old 
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 Table 1A – Continued 
 
Study DMUs DEA orientation Inputs Outputs Environmental variables
Spinks, J. & Hollingsworth, B. 
(2009)
28 OECD/WHO 
countries
Output-oriented 1.School expectancy years                                   
2.Total unemployment rate                           
3.GDP per capita                                
3.Total health expenditure (US$, 
PPP)
OECD dataset: 1.Life expectancy at 
birth                                                                   
WHO dataset:1. Disability adjusted 
life years
Afonso and Aubyn (2006 and 2011) 24 OECD 
countries
Output-oriented 1.Number of acute care beds                  
2.Number of MRI units                      
3.Number of physicians         
4.Number of nurses
1.Life expectancy                     
2.Infant Survival Rate                 
3.Potencial Years of Life Not  Lost
Non-discretionary variables used 
in DEA bootstrapping and Tobit 
regression:                             
1.GDP per capita                     
2.Education level                        
3.Tobacco consumption                    
4.Obesity
Santos et al. (2012) 52 low- and 
middle-income 
countries
Output-oriented 1.Prevention of mother-to-child HIV 
transmission domestic
spending from public and 
international financing sources 
(million US$
1.Reported number of pregnant 
women tested for HIV                 
2.Number of pregnant women living 
with HIV who received 
antiretrovirals for preventing mother-
to-child transmission                         
3.Reported number of infants born to 
women living with HIV receiving 
antiretrovirals for preventing mother-
to-child transmission                  
4.Reported number of infants born to 
women living with HIV receiving co-
trimoxazole prophylaxis within 2 
months of birth 
1.People aged 15 years and older 
who can, with understanding,both 
read and write                                                        
2.People living in urban areas                           
3.Total health expenditure (million 
US$)                                         
4.Political stability and absence of 
violence/terrorism
Hadad, S.et al. (2013) 31 OECD 
countries
Output-oriented Inputs model I:                                                 
1a.Number of  physicians                             
2a.Number of inpatient beds         
Inputs model II:                      
1b.GDP per capita  (US$, PPP)                                                         
2b.Consumption of fruit and 
vegetables per capita                                      
Model I and II:                         
3.Health expenditure per capita 
(US$, PPP)
1.Life expectancy at birth                                    
2.Infant survival rate
Variables used in the regression 
models:                                                 
1.Fat intake                             
2.Public expenditure                                  
3.Unemployment                                         
4.Gini index            
5.Environmental performance 
index
